新闻室 :: Repligen

公告

Date	Announcement

2022 年9月19日	Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement. Read More
February 15, 2022	Repligen Launches AAV Affinity Resins for Gene Therapy Purification. Read More
2021年12月16日	Repligen Acquires BioFlex Solutions, LLC. Read more
2017年11月5日	Repligen Releases Inaugural Sustainability Report. Read More
2021 年9月16日	Repligen Announces Agreement to Acquire Avitide Inc. Read More
2021 年9月9日	Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies Read More
2021 年9月3日	Repligen Extends Long Term Supply Agreement with Cytiva for Affinity Ligands. Read More
2021年6月22日	Repligen Corporation Announces Agreement to Acquire Polymem S.A. Read More
February 8, 2021	Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines. Read More
2020年10月27日	Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions. Read More
2020年10月1日	Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines. Read More
2020年6月29日	Repligen Announces Agreement to Acquire Engineered Molding Technology. Read More
2019年4月4日	Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies. Read More
Septermber 4, 2018	Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors. Read More
2018年6月28日	Repligen选择Purolite Life Sciences作为新型高性能配基商业化合作伙伴。阅读全文
2018年6月27日	Repligen宣布与Navigo Proteins达成下一代亲和配基独家合作开发协议。阅读全文
2017年6月23日	Repligen Corporation与 Spectrum Inc. 宣布合并。阅读全文
2016年12月15日	Repligen acquires TangenX Technology Corporation. Read More
2016年10月4日	Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification. Read More
2016年4月4日	Repligen 收购 Atoll GmbH。阅读全文

最新动态

Date	Title	出版物

July 26, 2021	Repligen Corporation set to significantly expand bioprocessing manufacturing capactiy and create 130+ new jobs in Waterford	IDA Ireland
2021年6月13日	Repligen buys Frech filtraion firm Polymem	Dan Stanton BioProcess International
2021年5月19日	Coronavirus Spike Protein Captures Resin Available for Future Deployment	GEN
February 12, 2021	New Affinity Resin for COVID-19 Vaccine Purification	GEN
February 10, 2021	Repligen and Navigo target next-wave COVID vaccines with affinity resin	Dan Stanton BioProcess International
2020年12月17日	America's Best Mid-size Companies Repligen: #15	Andrea Murphy, Hank Tucker Forbes
2017年11月19日	Repligen CEO Tony Hunt Knows Why Success Takes Time	Marilyn Munch Investor's Business Daily
2020年10月28日	Repligen strengthens downstream offering with $200m ARTeSYN acquisition	Dan Stanton BioProcess International
2020年10月8日	Navigo and Repligen Team on COVID-19 Vaccine Affinity Resin	Dan Stanton BioProcess International
2020 年9月1日	Continuous Processing: A Step on the Way to Bioprocess 4.0	Gareth John Macdonald GEN
July 1, 2020	Repligen boosting single-use portfolio with Engineered Molding Technology buy	BPI Staff BioProcess International
February 24, 2020	Repligen up on OPUS® and Gene Therapy Demand	Dan Stanton BioProcess International
2019年10月1日	Using Alternating Tangential Flow with Fed-Batch Cultures	GEN
2019年8月12日	Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application. Samsung BioLogics’ cell culture technique to cut production life by 30% Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application Samsung BioLogics implants cell-culturing tech	Samsung Biologics Pulse News Yahoo News Korea Biomed
2019年5月20日	OPUS focus: Repligen expands to support chromatography demand	Dan Stanton BioProcess International

News Room archive

新闻联系方式

Sondra Newman
高级总监，投资者关系

press @ repligen.com

电话：781.250.0111
免费电话：800.622.2259
传真：781.250.0115

下载 Repligen 商标

公告

Date

Announcement

最新动态

Date

Title

出版物

新闻联系方式